SEE ALSO...
Items 11 to 16 of 16 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin can decrease the expression of PC-PLD by specifically inhibiting PI3K, which leads to the downregulation of the AKT signaling pathway and reduced transcriptional activation of the PC-PLD gene. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine can inhibit DNA methylation, potentially causing the demethylation of the PC-PLD gene promoter region and reducing its expression by limiting the binding of methyl-CpG-binding proteins that repress transcription. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $56.00 $260.00 $416.00 | 129 | |
Sorafenib has the ability to inhibit multiple kinases which are responsible for the phosphorylation of transcription factors that control PC-PLD expression, potentially leading to decreased levels of the enzyme. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD 98059 can inhibit MEK1/2, leading to a reduction in ERK/MAPK pathway signaling and a consequent decrease in transcription factors that drive PC-PLD gene expression. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125, as a JNK inhibitor, could lead to reduced activity of transcription factors that are crucial for the expression of PC-PLD, resulting in lower enzyme levels. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126 may inhibit MEK1/2, thereby reducing ERK/MAPK pathway signaling and ultimately leading to decreased expression of the PC-PLD gene by reducing the activation of its transcription factors. | ||||||